Jim van Os - Towards Resilience and Possibilities and Away from Diseases and Symptoms

Jim van Os - Towards Resilience and Possibilities and Away from Diseases and Symptoms

This week on MIA Radio, we interview Professor Jim van Os. Professor van Os is Chairman of the Division of Neuroscience at Utrecht University Medical Centre, Utrecht, The Netherlands, and Visiting Professor of Psychiatric Epidemiology at King's College, Institute of Psychiatry in London. He trained in Psychiatry in Casablanca, Bordeaux and the Institute of Psychiatry and the Maudsley Royal Hospital in London.

We last spoke with Jim for the podcast in August 2017 and this time we focus on a recent paper written by Jim and co-authors that was published in the journal World Psychiatry in January 2019. The paper is entitled 'The diagnosis evidence-based group-level symptom-reduction model as organizing principle for mental health care. Time for change?'

In this episode we discuss:
  • What the diagnosis evidence-based group-level symptom-reduction model is and how it currently informs mainstream mental healthcare.
  • How mental health funding and mental health professional partners work together to monitor and assess the effects of current evidence-based interventions.
  • How this curative medical model is attractive, but often fails to work for patients.
  • That the focus on biological, brain-based diseases and symptoms conflicts with the experience of people who are attempting to develop a narrative view of their difficulties and suffering.
  • That the paper is an attempt to start a discussion about building a synthesis between the diagnosis, symptom-based medical world and the lived experience of individual people.
  • How the creation of specific and discrete diagnoses has reinforced the symptom-led approach to mental health and has also necessitated the stratification of doctors into silos of expertise.
  • How Jim favors a spectrum-based approach over a fixed diagnosis and that an example is autism spectrum disorder as described in DSM V.
  • The limitations of using 'target symptom reduction' as an outcome measure for mental health.
  • That symptom reduction can be beneficial in the short-term but is not a good long-term measure of recovery.
  • That the paper attempts to make clear how important individual experiences are and the need to be sensitive to the existential domain, saying "restoration of health is not the goal, it is the means to enable a person to find and pursue meaningful goals, accordingly, the person's existential values become central".
  • That the evidence suggests that any treatment effect or improvement is often down to meaningful interaction rather than the specific expertise of the treating professional.
  • That, in many countries, we still see a huge gulf between mental healthcare and social care which remain separate and remote from each other and that this separation is not how the person experiences their world.
  • The importance of including lived experience in the evidence base, particularly because randomized controlled trials, considered the gold standard of evidence, are often not conclusive in the field of mental health.
  • That, in mental health, evidence shows that 30% to 40% of the response is down to placebo and the expectation of being helped.
  • That the desire is to make the existential domain the primary lens through which to view human experience and to respond to mental or emotional suffering.
  • That, arguably, 'love is the most powerful evidence-based treatment in mental health'.

Relevant links:

Professor Jim van Os

The evidence-based group-level symptom-reduction model as the organizing principle for mental health care: time for change?

Tedx: Maastricht, Connecting to Madness

ISPS Liverpool Conference Jim Van Os Keynote Address

Schizophrenia does not exist

© Mad in America 2019

Episoder(290)

Mitochondria and Energetic Failures - A New Understanding of Antidepressant Withdrawal? An Interview with Chris Masterjohn

Mitochondria and Energetic Failures - A New Understanding of Antidepressant Withdrawal? An Interview with Chris Masterjohn

This week, we are joined by Chris Masterjohn, PhD. Chris is a nutritional scientist, a former professor, and the founder of Mitome. With a PhD in nutritional science and years of research in mitochond...

21 Jan 43min

Why Critical Mental Health Knowledge Is Essential for Ethical Practice: An Interview with Jan DeFehr

Why Critical Mental Health Knowledge Is Essential for Ethical Practice: An Interview with Jan DeFehr

Jan N. DeFehr is an associate professor in the Faculty of Education at the University of Winnipeg and an associate of The Taos Institute and a member of the Faculty for Palestine, Manitoba. She is als...

14 Jan 47min

ADHD Diagnoses, Examining the Psyche, Withdrawal and PSSD Risks, ECT Harms and More: Robert Whitaker Answers Reader Questions

ADHD Diagnoses, Examining the Psyche, Withdrawal and PSSD Risks, ECT Harms and More: Robert Whitaker Answers Reader Questions

In our first podcast of 2026, Robert Whitaker joins us to answer questions submitted by Mad in America readers and listeners. We discuss the validity of ADHD diagnoses, withdrawal and sexual dysfuncti...

7 Jan 48min

Learning to Soar: A Conversation With Artist Kev G Mor

Learning to Soar: A Conversation With Artist Kev G Mor

Musician and artist Kev G Mor joins us to discuss his experience of psychosis, his daily support strategies, and the pros and cons of having a hundred-pound pit bull terrier for emotional support. Kev...

17 Des 202543min

Antidepressant Withdrawal: Finding an Astronomical Perspective - A Conversation with Safa Askeri

Antidepressant Withdrawal: Finding an Astronomical Perspective - A Conversation with Safa Askeri

Safa Askeri joins us to discuss his experience of antidepressant withdrawal and the gaslighting he was subjected to as he raised concerns with his doctors. "After this happened to me, I know that I ca...

19 Nov 202537min

Psychiatric Drugs: The Real World is Where the Harms Live

Psychiatric Drugs: The Real World is Where the Harms Live

Joining us for a roundtable discussion are Brooke Siem, David Antonuccio, Kim Witzak, Angie Peacock and David Healy. They discuss the challenges of openly discussing psychiatric drug withdrawal, the t...

29 Okt 202545min

Medical Organizations Turn Blind Eye to Harms of Maternal Antidepressant Use: A Conversation With Adam Urato and Joanna Moncrieff

Medical Organizations Turn Blind Eye to Harms of Maternal Antidepressant Use: A Conversation With Adam Urato and Joanna Moncrieff

On July 21st 2025, the FDA convened a hearing on maternal use of antidepressants during pregnancy and the impact this use has on fetal development. Around 400,000 children in the United States are bor...

8 Okt 202548min

Psychotherapy, Spirituality, and Democratic Socialism: A Conversation with Frank Gruba-McCallister

Psychotherapy, Spirituality, and Democratic Socialism: A Conversation with Frank Gruba-McCallister

Frank Gruba-McCallister is a clinical psychologist, educator, and scholar whose career spans more than three decades of teaching and academic leadership. He served as Vice President of Academic Affai...

24 Sep 202544min

Populært innen Helse

lydartikler-fra-aftenposten
fastlegen
hvordan-har-du-det-mann
rss-gukild-johaug
psykodrama
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-garne-damer
foreldreradet
rss-lopedrommen
morten-ramm-lar-kakla-ga-til-du-sovner
hjernesterk
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
klimaks
g-punktet
treningsprat
sinnsyn
helsetipspodden
rss-kull
rss-kunsten-a-leve